Related Experiment Video
Updated: Mar 23, 2026

23:33
The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
84.7K
Warfarin and Drug Interactions: Prescribing Vigilance
Dental Update
|March 31, 2016
Summary
Dental patients taking warfarin experienced bruising after prescriptions for metronidazole and miconazole. Patient awareness of drug interactions with warfarin prevented serious adverse events, highlighting the need for practitioner vigilance.
Area of Science:
- Pharmacology
- Oral Medicine
- Drug Interactions
Background:
- Warfarin is a common anticoagulant medication.
- Metronidazole and miconazole are frequently prescribed by general dental practitioners (GDPs).
- Potential for serious drug interactions exists between these medications.
Observation:
- A patient on warfarin developed bruising after being prescribed metronidazole and miconazole.
- The patient identified the potential drug interaction by reading medication leaflets.
- The patient proactively ceased warfarin intake, preventing potential hemorrhage.
Findings:
- Concurrent use of metronidazole and miconazole with warfarin poses a significant risk of drug interaction.
- Patient education and engagement are crucial for medication safety.
- This case underscores the potential for severe adverse events if drug interactions are not managed.
Implications:
- Dental practitioners must maintain updated knowledge of drug interactions, particularly with commonly prescribed medications.
- Thorough patient medical and drug histories are essential before prescribing.
- Continuing professional development (CPD) in pharmacotherapeutics is vital for dental professionals to ensure patient safety.
Related Concept Videos
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.7K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.7K
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
464
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...
464
Pharmacokinetics: Drug–Drug Interactions
636
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
636
Drug toxicity: Drug–Drug Interaction
314
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
314
Pharmacovigilance
1.9K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.9K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.3K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.3K

